Cargando…

Decreased Global EEG Synchronization in Amyloid Positive Mild Cognitive Impairment and Alzheimer’s Disease Patients—Relationship to APOE ε4

The apolipoprotein E (APOE) ε4 allele is a risk factor for Alzheimer’s disease (AD) that has been linked to changes in brain structure and function as well as to different biological subtypes of the disease. The present study aimed to investigate the association of APOE ε4 genotypes with brain funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smailovic, Una, Johansson, Charlotte, Koenig, Thomas, Kåreholt, Ingemar, Graff, Caroline, Jelic, Vesna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533770/ https://www.ncbi.nlm.nih.gov/pubmed/34679423 http://dx.doi.org/10.3390/brainsci11101359

Ejemplares similares

Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
por: Smailovic, Una, et al.
Publicado: (2019)

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism
por: Smailovic, Una, et al.
Publicado: (2020)

Decreased Electroencephalography Global Field Synchronization in Slow-Frequency Bands Characterizes Synaptic Dysfunction in Amnestic Subtypes of Mild Cognitive Impairment
por: Smailovic, Una, et al.
Publicado: (2022)

Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer’s Disease
por: Smailovic, Una, et al.
Publicado: (2021)

EEG time signature in Alzheimer´s disease: Functional brain networks falling apart
por: Smailovic, Una, et al.
Publicado: (2019)

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal‐dominant Alzheimer's disease
por: Almkvist, Ove, et al.
Publicado: (2022)

Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer’s disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease
por: Kramberger, Milica Gregoric, et al.
Publicado: (2012)

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020)

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)

Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
por: Wesenhagen, Kirsten E.J., et al.
Publicado: (2022)

APOEε4 potentiates the relationship between amyloid-β and tau pathologies
por: Therriault, Joseph, et al.
Publicado: (2020)

The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
por: Bonham, Luke W., et al.
Publicado: (2016)

APOE ε4-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer’s disease
por: Kim, Hongwon, et al.
Publicado: (2022)

Relationship between the Presence of the ApoE ε4 Allele and EEG Complexity along the Alzheimer’s Disease Continuum
por: Gutiérrez-de Pablo, Víctor, et al.
Publicado: (2020)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
por: Padayachee, E.R., et al.
Publicado: (2016)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction
por: Düzel, Emrah, et al.
Publicado: (2022)

Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele
por: Roberts, Rosebud O., et al.
Publicado: (2015)

Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
por: Rosenberg, Anna, et al.
Publicado: (2019)

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months
por: Thai, Christine, et al.
Publicado: (2015)

Higher Level of Mismatch in APOE ε4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid
por: Vogelgsang, Jonathan, et al.
Publicado: (2019)

Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment
por: Li, Weihua, et al.
Publicado: (2022)

Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
por: Martiskainen, Henna, et al.
Publicado: (2018)

Subjective Cognitive Impairment Subjects in Our Clinical Practice
por: Garcia-Ptacek, Sara, et al.
Publicado: (2014)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
por: Müller-Gerards, Diana, et al.
Publicado: (2019)

Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment
por: Liu, Xiaocao, et al.
Publicado: (2022)

Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
por: Caillaud, Martial, et al.
Publicado: (2019)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessation
por: Ashare, Rebecca L., et al.
Publicado: (2012)

Age‐dependent effects of APOE ε4 in preclinical Alzheimer's disease
por: Bonham, Luke W., et al.
Publicado: (2016)

APOEε4 and risk of Alzheimer’s disease – time to move forward
por: Lefterov, Iliya, et al.
Publicado: (2023)

APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
por: Jordà‐Siquier, Tomàs, et al.
Publicado: (2022)

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
por: Huentelman, Matt, et al.
Publicado: (2019)

The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment
por: Wang, Xiwu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ijcb12cm2mcrb78v454crajkv7